Influenza Diagnostic Market Size, Share, Revenue, Trends

The Immunofluorescence Assay Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Immunofluorescence Assay Market:

https://www.thebusinessresearchcompany.com/report/immunofluorescence-assay-global-market-report

According to The Business Research Company’s Immunofluorescence Assay Global Market Report 2024, The immunofluorescence assay market size has grown strongly in recent years. It will grow from $3.18  billion in 2023 to $3.43  billion in 2024 at a compound annual growth rate (CAGR) of 8.1%.  The  growth in the historic period can be attributed to increased disease diagnosis, rise in research and development, rise in autoimmune diseases, increased cancer diagnostics, rise in virology research.

The immunofluorescence assay market size is expected to see strong growth in the next few years. It will grow to $4.9  billion in 2028 at a compound annual growth rate (CAGR) of 9.3%.  The growth in the forecast period can be attributed to increasing personalized medicine, rising infectious disease surveillance, rising autoimmune disorders, rising point-of-care testing, increasing global health preparedness. Major trends in the forecast period include multiplexing assays, automation and robotics, high-content imaging, advanced fluorophores, digital pathology integration.

The increasing prevalence of chronic diseases is significantly driving the growth of the immunofluorescence assay market. The changing lifestyle, dietary habits, and improper weight management are contributing to the rapid growth in chronic conditions and a few prolonged chronic infections are leading to cancerous risk. The growing prevalence of chronic disease is expected to boost demand for immunofluorescence assays as they are widely used in diagnosis and drug development activities. For instance, according to the study published by the Centers for Disease Control and Prevention, approximately 6 in 10 adults in the USA are affected by chronic disease, and it is also accounting for $3.8 trillion in annual healthcare costs. Therefore, the increasing prevalence of chronic diseases is expected to boost demand for immunofluorescence assay during forecast period.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=6778&type=smp

The immunofluorescence assay market covered in this report is segmented –

1) By Type: Direct Immunofluorescence, Indirect Immunofluorescence

2) By Product: Reagents, Instruments, Antibodies, Kits, Consumables and Accessories

3) By Disease: Cancer, Infectious Disease, Cardiovascular Diseases, Autoimmune Diseases, Other Diseases

4) By End User: Academic & Research Institutions, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Hospitals & Diagnostic Centers

Technological advancement is a key trend gaining popularity in the immunofluorescence assay market. The companies operating in immunofluorescence assay are focusing on developing technologically innovative products to meet specific technical demands for the diagnostic of new viruses such as COVID-19 and strengthen their market position. For instance, in March 2022, LumiraDx, a UK-based developer of point-of-care diagnostics, received emergency approval for LumiraDx SARS-CoV-2 Ag Test, a microfluidic immunofluorescence assay, designed for qualitative nucleocapsid protein antigen detection from nasal swab samples.

The immunofluorescence assay market report table of contents includes:

 

1. Executive Summary
2. Immunofluorescence Assay Market Characteristics
3. Immunofluorescence Assay Market Trends And Strategies
4. Immunofluorescence Assay Market – Macro Economic Scenario
5. Global Immunofluorescence Assay Market Size and Growth

.

.

.

31. Global Immunofluorescence Assay Market Competitive Benchmarking
32. Global Immunofluorescence Assay Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Immunofluorescence Assay Market
34. Immunofluorescence Assay Market Future Outlook and Potential Analysis
35. Appendix

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

 

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model